Skip to main content
Log in

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bertilsson L, Eichelbaum M, Mellström B, Säwe J, Schulz H-U, Sjöqvist F (1980) Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Life Sci 27: 1673–1677

    Google Scholar 

  • Cooper RG, Evans DAP (1984) Oxidation polymorphism has clinical relevance. Lancet 2: 227

    Google Scholar 

  • Dayer P, Balant L, Courvoisier F, Küpfer A, Kubli A, Gorgia A, Fabre J (1982) The genetic control of bufuralol metabolism in man. Eur J Drug Metab Pharmacokinet 7: 73–77

    Google Scholar 

  • Dayer P, Gasser R, Gut J, Kronbach T, Robertz GM, Eichelbaum M, Meyer UA (1984) Characterization of a common genetic defect of cytochrome P-450 mediated function (debrisoquine-sparteine type polymorphism). Biochem Biophys Res Commun 125: 374–380

    Google Scholar 

  • Dayer P, Leemann T, Marmy A, Rosenthaler J (1985) Interindividual variation of beta-adrenoceptor blocking drugs plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol. Eur J Clin Pharmacol 28: 149–153

    Google Scholar 

  • Dengler HJ, Eichelbaum M (1977) Polymorphismen und Defekte des Arzneimittelstoffwechsels als Ursache toxischer Reaktionen. Arzneimittelforsch 27: 1836–1844

    Google Scholar 

  • Distlerath L, Guengerich FP (1984) Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme. Proc Natl Acad Sci USA 81: 7348–7352

    Google Scholar 

  • Gut J, Gasser R, Dayer P, Kronbach T, Catin T, Meyer UA (1984) Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P-450 isozyme with high activity for bufuralol hydroxylation. FEBS Lett 173: 287–290

    Google Scholar 

  • Hori R, Okumura K, Inui KI, Yasuhara M, Yamada K, Sakurai T, Kawai C (1984) Quinidine-induced rise in ajmaline plasma concentration. J Pharm Pharmacol 36: 202–204

    Google Scholar 

  • Idle JR, Smith RL (1984) The debrisoquine hydroxylation gene: a gene of multiple consequence. In: Lemberger L, Reidenberg M (eds) Proceedings of the Second World Conference on Clinical Pharmacology and Therapeutics. ASPET, Bethesda, pp 148–164

    Google Scholar 

  • Leemann T, Dayer P, Balant L, Buri P (1984) Direct determination of R- and S-metoprolol in biological fluids by ion-pair-HPLC. Experientia 40: 647

    Google Scholar 

  • Lennard MS, Silas JH, Freestone S, Threvethick J (1982) Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol 14: 301–303

    Google Scholar 

  • Lennard MS, Silas JH, Freestone S, Tucker GT, Ramsay LE, Woods HF (1983) Differential stereoselective metabolism of metoprolol in extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol 16: 586P-587P

    Google Scholar 

  • Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet 2: 584–586

    Google Scholar 

  • Meyer UA (1984) The clinical pharmacology of cytochrome P-450. In: Lemberger L, Reidenberg M (eds) Proceedings of the Second World Conference on Clinical Pharmacology and Therapeutics. ASPET, Bethesda, pp 331–341

    Google Scholar 

  • Otton SV, Inaba T, Kalow W (1984) Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs. Life Sci 34: 73–80

    Google Scholar 

  • Price-Evans D, Mahgoub A, Sloan TP, Idle JR, Smith RL (1980) A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet 17: 102–105

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leemann, T., Dayer, P. & Meyer, U.A. Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers. Eur J Clin Pharmacol 29, 739–741 (1986). https://doi.org/10.1007/BF00615971

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00615971

Keywords

Navigation